CoChat
Sign Up
Cited by 31Transcranial Magnetic Stimulation StudiesNeurological disorders and treatmentsTreatment of Major Depression

Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression (SAINT-TRD)

Open access
Cole, E., Gulser, M., Stimpson, K., Bentzley, B., Hawkins, J., Xiao, X., Schatzberg, A., Sudheimer, K. +1 more·2019·Brain Stimulation
DOI 10.1016/j.brs.2018.12.299

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brs.2018.12.299

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 90 · Cited by 31

Research works printed but not linked: 80

  1. Reddy M. Depression: The disorder and the burden. Indian J. Psychol. Med. 2010;32(1):1-2.
  2. World Health Organisation. WHO | Suicide data. WHO Website 2016; doi:10.1109/TSE.2011.123 · DOI
  3. Friedrich MJ. Depression Is the Leading Cause of Disability Around the World. JAMA 2017;317(15):1517.
  4. Berlim MT, Van Den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: A systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol. Med. 2014;44(2):225-239.
  5. Heijnen WT, Birkenhäger TK, Wierdsma AI, Van Den Broek WW. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: A meta- analysis. J. Clin. Psychopharmacol. 2010;30(5):616-619.
  6. Sinyor M, Schaffer A, Levitt A. The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: A review. Can. J. Psychiatry 2010;55(3):126-135.
  7. Penn E, Tracy DK. The drugs don't work? antidepressants and the current and future pharmacological management of depression. Ther. Adv. Psychopharmacol. 2012;2(5):179-188.
  8. Blier P. Optimal use of antidepressants: when to act?. J. Psychiatry Neurosci. 2009;34(1):80.
  9. Husain MM et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. J. Clin. Psychiatry 2004;65(4):485-491.
  10. Perera T et al. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder [Internet]. Brain Stimul. 2016;9(3):336-346.
  11. George MS, Talyor JJ, Short EB. The Expanding Evidence Base for rTMS Treatment of Depression. Curr. Opin. Psychiatry 2013;26(1):13-18.
  12. Hallett M. Transcranial magnetic stimulation and the human brain [Internet]. Nature 2000;406(6792):147-150.
  13. Huerta PT, Volpe BT. Transcranial magnetic stimulation, synaptic plasticity and network oscillations. J. Neuroeng. Rehabil. 2009;6(7). doi:10.1186/1743-0003-6-7 · DOI · Paper page
  14. Ogiue-Ikeda M, Kawato S, Ueno S. The effect of repetitive transcranial magnetic stimulation on long-term potentiation in rat hippocampus depends on stimulus intensity. Brain Res. 2003;993(1-2):222-226.
  15. Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol. Psychiatry 2012;72(7):595-603.
  16. Kito S et al. Transcranial Magnetic Stimulation Modulates Resting EEG Functional Connectivity Between the Left Dorsolateral Prefrontal Cortex and Limbic Regions in Medicated Patients With Treatment-Resistant Depression. J. Neuropsychiatry Clin. Neurosci. 2016;29(2):155-159.
  17. Singh A et al. Intermittent theta burst stimulation at personalized targets reduces the functional connectivity of the default mode network in healthy subjects [Internet]. bioRxiv [published online ahead of print: 2019]; doi:10.1101/646265 · DOI
  18. Huang YZ, Rothwell JC. The effect of short-duration bursts of high-frequency, low-intensity transcranial magnetic stimulation on the human motor cortex. Clin. Neurophysiol. 2004;115(5):1069-1075.
  19. Blumberger DM et al. Intermittent theta-burst versus 10 Hz left dorsolateral prefrontal rTMS for treatment resistant depression: preliminary results from a two-site, randomized, single blind non-inferiority trial [Internet]. Brain Stimul. 2015;8(2):329.
  20. Lynch G, Kramár EA, Babayan AH, Rumbaugh G, Gall CM. Differences between synaptic plasticity thresholds result in new timing rules for maximizing long-term potentiation [Internet]. Neuropharmacology 2013;64:27-36.
  21. Thomson AC et al. No additive meta plasticity effects of accelerated iTBS with short inter- session intervals. Brain Stimul. [published online ahead of print: 2019]; doi:10.1016/j.brs.2019.05.012 · DOI
  22. George MS et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial.. Am. J. Psychiatry 1997;154(12):1752-1756.
  23. Yip AG et al. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial [Internet]. Brain Stimul. 2017;10(4):847-849.
  24. Weigand A et al. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites [Internet]. Biol. Psychiatry 2018;84(1):28-37.
  25. Williams NR et al. High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression. Brain 2018;141(3):e18.
  26. Desmyter S et al. Accelerated Intermittent Theta Burst Stimulation for Suicide Risk in Therapy-Resistant Depressed Patients: A Randomized, Sham-Controlled Trial. Front. Hum. Neurosci. 2016;10:1-7.
  27. Duprat R et al. Accelerated intermittent theta burst stimulation treatment in medication- resistant major depression: A fast road to remission?. J. Affect. Disord. 2016;200:6-14.
  28. Chung SW et al. Impact of different intensities of intermittent theta burst stimulation on the cortical properties during TMS-EEG and working memory performance. Hum. Brain Mapp. 2018;39(2):783-802.
  29. Chung SW, Hoy KE, Fitzgerald PB. Theta-burst stimulation: A new form of tms treatment for depression?. Depress. Anxiety 2015;32(3):182-192.
  30. Alkhasli I, Sakreida K, Mottaghy FM, Binkofski F. Modulation of Fronto-Striatal Functional Connectivity Using Transcranial Magnetic Stimulation [Internet]. Front. Hum. Neurosci. 2019;13:190.
  31. Stokes MG et al. Simple Metric For Scaling Motor Threshold Based on Scalp-Cortex Distance: Application to Studies Using Transcranial Magnetic Stimulation [Internet]. J. Neurophysiol. 2005;94(6):4520-4527.
  32. Ozten E, Sayar GH, Karamustafalioglu O. Hypomanic shift observed during rTMS treatment of patients with unipolar depressive disorder: Four case reports. Ann. Gen. Psychiatry 2013;12(1):1-5.
  33. O'neil-Pirozzi TM, Goldstein R, Strangman GE, Glenn MB. Testre-test reliability of the Hopkins Verbal Learning Test-Revised in individuals with traumatic brain injury. Brain Inj. 2012;26(12):1425-1430.
  34. Benedict RHB, Groninger L, Schretlen D, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: Studies of normal performance, reliability, and, validity. Psychol. Assess. 1996;8(2):145-153.
  35. Delis DC, Kramer JH, Kaplan E, Holdnack J. Reliability and validity of the Delis-Kaplan Executive Function System: An update. J. Int. Neuropsychol. Soc. 2004;10(02):301-303.
  36. Timmerby N, Andersen JH, Søndergaard S, Østergaard SD, Bech P. A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6). Psychother. Psychosom. 2017;86(3):141-149.
  37. Carpenter LL et al. Transcranial magnetic stimulation (TMS) for major depression: A multisite, naturalistic, observational study of acute treatment outcomes in clinical practice [Internet]. Depress. Anxiety 2012;29(7):587-596.
  38. Janicak PG et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: Assessment of relapse during a 6-month, multisite, open-label study [Internet]. Brain Stimul. 2010;3(4):187-199.
  39. Harris KM, Kater SB. Dendritic Spines: Cellular Specializations Imparting Both Stability and Flexibility to Synaptic Function. Annu. Rev. Neurosci. 1994;17(1):341-371.
  40. Tse NY et al. The effect of stimulation interval on plasticity following repeated blocks of intermittent theta burst stimulation. Sci. Rep. 2018;8(1):8526.
  41. Goldsworthy MR, Pitcher JB, Ridding MC. The application of spaced theta burst protocols induces long-lasting neuroplastic changes in the human motor cortex. Eur. J. Neurosci. 2012;35(1):125-134.
  42. Goldsworthy MR, Pitcher JB, Ridding MC. The application of spaced theta burst protocols induces long-lasting neuroplastic changes in the human motor cortex [Internet]. Eur. J. Neurosci. 2012;35(1):125-134.
  43. Nyffeler T, Cazzoli D, Hess CW, Müri RM. One session of repeated parietal theta burst stimulation trains induces long-lasting improvement of visual neglect. Stroke 2009;40(8):2791- 2796.
  44. Chung SW, Rogasch NC, Hoy KE, Fitzgerald PB. The effect of single and repeated prefrontal intermittent theta burst stimulation on cortical reactivity and working memory [Internet]. Brain Stimul. 2018;11(3):566-574.
  45. Hoshi E. Functional specialization within the dorsolateral prefrontal cortex: A review of anatomical and physiological studies of non-human primates. Neurosci. Res. 2006;54(2):73-84.
  46. Oathes DJ et al. Individualized non-invasive brain stimulation engages the subgenual anterior cingulate and amygdala. bioRxiv [published online ahead of print: 2018]; doi:https://doi.org/10.1101/503441 · DOI
  47. Vink JJT et al. A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation. Hum. Brain Mapp. 2018;39(11):4580-4592.
  48. Mir-Moghtadaei A et al. Concordance between BeamF3 and MRI-neuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex. Brain Stimul. 2015;8(5):965-973.
  49. Li CT et al. Efficacy of prefrontal theta-burst stimulation in refractory depression: A randomized sham-controlled study. Brain 2014;137(7):2088-2098.
  50. Kaster TS et al. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial. Neuropsychopharmacology 2018;43(11):2231-2238.
  51. Jorge RE, Robinson RG, O'Brien JT. Top cited papers in international psychogeriatrics: 5. a controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int. Psychogeriatrics 2009;21(5):855-857.
  52. Kaster TS et al. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. Am. J. Psychiatry 2019;176(5):367-375.
  53. Williams NR, Okun MS. Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J. Clin. Invest. 2013;123(11):4546-4556.
  54. Fregni F et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 2006;9(6):641-654.
  55. George MS et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Arch. Gen. Psychiatry 2010;67(5):507-516.
  56. O'Reardon JP et al. Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biol. Psychiatry 2007;62(11):1208-1216.
  57. Pittenger C, Duman RS. Stress, Depression and Neuroplasticity: A Convergence of Mechanisms. Neuropsychopharmacology 2008;33(1):88-109.
  58. Pridmore S, Erger S, Rybak M, Kelly E, May T. Early relapse (ER) transcranial magnetic stimulation (TMS) in treatment resistant major depression [Internet]. Brain Stimul. 2018;11(5):1098-1102.
  59. Williams NR et al. Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression [Internet]. Brain Stimul. 2016;9(6):897-904.
  60. Williams NR et al. Optimization of epidural cortical stimulation for treatment-resistant depression. Brain Stimul. 2018;11(1):239-240.
  61. Murrough JW et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression [Internet]. Biol. Psychiatry 2013;74(4):250- 256.
  62. Shiroma PR et al. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression [Internet]. J. Affect. Disord. 2014;155(1):123-129.
  63. Diamond PR et al. Ketamine infusions for treatment resistant depression: A series of 28 patients treated weekly or twice weekly in an ECT clinic. J. Psychopharmacol. 2014;28(6):536- 544.
  64. Correia-Melo FS et al. Rapid infusion of esketamine for unipolar and bipolar depression: A retrospective chart review. Neuropsychiatr Dis Treat 2017;13:1627-1632.
  65. Williams NR et al. Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am. J. Psychiatry 2018;175(12):1205-1215.
  66. Slade EP, Jahn DR, Regenold WT, Case BG. Association of electroconvulsive therapy with psychiatric readmissions in US hospitals. JAMA Psychiatry 2017;74(8):798-804.
  67. Sackeim HA. Modern electroconvulsive therapy: Vastly improved yet greatly underused. JAMA Psychiatry 2017;74(8):779-780.
  68. Kellner CH et al. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am. J. Psychiatry 2005;162(5):977-982.
  69. Brim RL, Miller FG. The potential benefit of the placebo effect in sham-controlled trials: Implications for risk-benefit assessments and informed consent. J. Med. Ethics 2013;39(11):703-707.
  70. Zhou C et al. A systematic review and meta-analysis of deep brain stimulation in treatment- resistant depression. Prog. Neuro-Psychopharmacology Biol. Psychiatry [published online ahead of print: 2018]; doi:10.1016/j.pnpbp.2017.11.012 · DOI · Paper page
  71. Dunner DL et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J. Clin. Psychiatry 2006;67(5):688-695.
  72. Feffer K et al. 1 Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomes. Eur. Neuropsychopharmacol. 2018;28(1):109-117.
  73. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability. Exp. Brain Res. 2000;133(4):425-430.
  74. Du X, Summerfelt A, Chiappelli J, Holcomb HH, Hong LE. Individualized brain inhibition and excitation profile in response to paired-pulse TMS. J. Mot. Behav. 2014;46(1):39-48.
  75. Schaworonkow N, Triesch J, Ziemann U, Zrenner C. EEG-triggered TMS reveals stronger brain state-dependent modulation of motor evoked potentials at weaker stimulation intensities [Internet]. Brain Stimul. 2019;12(1):110-118.
  76. Chung SW et al. The effects of individualised intermittent theta burst stimulation in the prefrontal cortex: A TMS-EEG study. Hum. Brain Mapp. 2019;40(2):608-627.
  77. Oberman L et al. Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome. Eur. J. Neurosci. 2012;36(6):2782-2788.
  78. Peinemann A et al. Long-lasting increase in corticospinal excitability after 1800 pulses of subthreshold 5 Hz repetitive TMS to the primary motor cortex. Clin. Neurophysiol. 2004;115(7):1519-1526.
  79. Volz LJ, Benali A, Mix A, Neubacher U, Funke K. Dose-dependence of changes in cortical protein expression induced with repeated transcranial magnetic theta-burst stimulation in the rat [Internet]. Brain Stimul. 2013;6(4):598-606.
  80. Okamoto M et al. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping.. Neuroimage 2004;21(1):99-111.

Authors
Cole, E., Gulser, M., Stimpson, K., Bentzley, B., Hawkins, J., Xiao, X., Schatzberg, A., Sudheimer, K., & Williams, N.
Affiliations
  • Stanford University (US)
  • Palo Alto University (US)
Corresponding author
  • Sudheimer, K.
  • Williams, N.
ORCID
Venue
Brain Stimulation
Publisher
Elsevier BV
Published
2019-03
Volume
12
Issue
2
Pages
402
ISSN
  • 1876-4754 (ISSN-L)
  • 1935-861X
DOI
10.1016/j.brs.2018.12.299
OpenAlex
W2951038923
Cited by
31
References
90
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2022: 3 · 2021: 9 · 2020: 6 · 2019: 1
FWCI
2.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Brain stimulation (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • National Institutes of Health (UL1TR001085, NIH T32, T32 035165, TR001085)
Topics
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
treatment-resistant depression, intermittent theta burst stimulation, neuromodulation, dorsolateral prefrontal cortex, treatment response prediction, left dorsolateral prefrontal cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review